Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

The CDC urges healthcare providers to preserve their current supply. 

Tetanus Vaccine Now Facing Shortages

The pTau217 antibody helps pinpoint pathological changes related to the disease. 

Alamar Biosciences and ALZpath Announce Collaboration Centered on Furthering Alzheimer’s Disease Research

The latest news for pharma industry insiders.

Pharma Pulse 3/5/24: How the Pandemic Changed the Way Pharma Looks at Data Integrity in 2024, ow Your Protein Needs Change as You Age & more

Momentum from the previous two years will propel the sector into the rest of 2024, says AM Best analysis.

Report: The Future of the Health Insurance Market Appears Stable

The purchase boosts the parties’ sterile liquid manufacturing capabilities.

Adragos Pharma, Prange Group Acquires Fresenius Kabi Plant

Pharma Pulse 3/4/24: Local Pharmacies on the Brink, People in MA Plans Experienced Delays in Accessing Care & more

A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics. 

Examining the Impact of the COVID-19 Pandemic on Patient Portal Use

With its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain. 

Streamlining for Safety: Navigating Changes and Trends in the Pharmaceutical Supply Chain Post-DSCSA

The offering reportedly helps avoid product quarantine.

Systech Introduces Solution for Managing Pharma Supply Chain Exceptions

A cohort study investigates a potential correlation between the stresses caused by Mother Nature and mental health. 

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right